World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: Netherlands Trial Register
Last refreshed on: 27 May 2013
Main ID:  NTR1701
Date of registration: 09/03/2009
Primary sponsor: University Maastricht (UM), Faculty of Psychology and Neuroscience
Public title: Het effect van Spironolactone op geheugenprestatie onder stressvolle omstandigheden.
Scientific title: The effect of Spironolactone on memory performance under stressful circumstances. - N/A
Date of first enrolment: 1/4/2009
Target sample size: 64
Recruitment status: complete
URL:  http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1701
Study type:  intervention
Study design:  Randomised: Yes; Masking: Double; Control: Placebo; Group: Parallel; Type: 2 or more arms, randomized  
Countries of recruitment
The Netherlands
Contacts
Name: T.  Smeets
Address:  University Maastricht (UM), GVO, P.O. Box 616, Peter Debeyeplein 1 6200 MD Maastricht The Netherlands
Telephone: +31 (0)43 3882194
Email: t.smeets@gvo.unimaas.nl
Affiliation: 
Name: T.  Smeets
Address:  University Maastricht (UM), GVO, P.O. Box 616, Peter Debeyeplein 1 6200 MD Maastricht The Netherlands
Telephone: +31 (0)43 3882194
Email: t.smeets@gvo.unimaas.nl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Healthy male volunteers aged 18-35y will be recruited for this study. They will undergo a short medical examination before participating.
Exclusion criteria: 1. Suffering from cardiovascular diseases, severe physical illness, hypertension, current or lifetime psychopathology or endocrine disorders;

2. Being on medication known to affect HPA-axis functioning;

3. Use of Acetyl Salicylic Acid;

4. Renal insufficiency;

5. Hyperkalemia .


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Healthy subjects

Intervention(s)
The current study will use a double-blind, placebo controlled design. One group will receive Spironolactone (400mg in a single dose on one day only) and engage in the Trier Social Stress Test (TSST; Kirschbaum et al. 1993) before undergoing memory tests; one group will receive the same dose of Spironolactone and engage in a non-stressful control task; another group will receive a placebo and be exposed to the TSST; while the fourth group will receive a placebo and engage in a non-stressful control task (n=16 per group).
Primary Outcome(s)
The main study parameter is the memory performance on the surprise recall test of the word list, learned 24 hours before, in the four experimental groups (stress vs non-stress X Spironolactone vs placebo). The memory performance on the recall test depends on the amount of remembered words from four different categories: stress related non-arousing words, stress-related arousing words, stress-unrelated non-arousing words and stress-unrelated arousing words. The validity of this procedure as well as these specific word lists has been shown elsewhere (Smeets et al., 2007, in press). For example, Smeets et al. (in press) recently showed that when learning coincided with stress exposure, immediate and delayed recall of stressor-related high arousing words is enhanced relative to stressor-unrelated words, at the expense of delayed recall of stressor-related low arousing words. Moreover, this enhanced learning and memory effect of post-stress learning correlated with stress-induced cortisol elevations in conjunction with high sympathetic activity as measured by salivary alpha-amylase, but not with changes in either of the hormones alone.
Secondary Outcome(s)
Secondary study parameters are the salivary cortisol and alpha-amylase levels at several time points during the experiment and heart rate and blood pressure levels throughout the experiment. Furthermore we would like to check the effects of Spironolactone on selective attention and working memory.
Secondary ID(s)
NL26301.068.08
Source(s) of Monetary Support
University Maastricht (UM), Faculty of Psychology and Neuroscience
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history